Quo vadis pharma industry?

Klin Farmakol Farm. 2014;28(1):5-7

Quo vadis pharma industry?

Jakub Rak^{1, 2}, Vladimír Král^{1, 2}: ¹ Ústav analytické chemie, Vysoká škola chemicko-technologická, Praha; ² Zentiva, a.s.

Where from and where the pharmaceutical industry walks? In recent years there has been a dramatic reassessment of goals of large

pharmaceutical companies from search for new substances to the reincarnation of the old molecules with new applications. Changes

of market conditions force industry to rigorous life cycle management of pharmaceuticals. Trends also show a shift away from small

molecules to biomedicine and sophisticated nanomedicine. The emphasis is slowly shifting from simply treating the quality of life,

from the universality to personalized medicine. Companies that do not adapt to these trends will face an uncertain and worrying future.